Figure 5.
Observed and physiologically‐based pharmacokinetic (PBPK) model‐simulated concentrations of paclitaxel in tissues (a) and plasma (b) following a dose of 175 mg/m2 in patients with solid tumors. Black dots represent observed data, and solid lines and dash lines represent the mean and 90% confidence intervals of the simulations from the proposed PBPK model.